Reuters logo
BRIEF-Thrombogenics cash and cash equivalents at Dec 31 down at 80.1 million euros
March 16, 2017 / 5:06 PM / 8 months ago

BRIEF-Thrombogenics cash and cash equivalents at Dec 31 down at 80.1 million euros

March 16 (Reuters) - Thrombogenics NV

* Cash and cash equivalents at Dec 31 80.1 million euros ($85.99 million) versus 101.4 million euros year ago

* Generated overall revenues of 7.1 million euros in 2016 Source text: bit.ly/2nwgfpn See also: Further company coverage: ($1 = 0.9315 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below